These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3133528)

  • 1. In-vitro activity of sulbactam-ampicillin combination.
    Moosdeen F; Lim VK
    Malays J Pathol; 1987 Aug; 9():85-8. PubMed ID: 3133528
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Fabbri A; Tacchella A; Belli ML; Losurdo G
    Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of beta-lactamase inhibitor sulbactam plus ampicillin against animal isolates of Pasteurella, Haemophilus, and Staphylococcus.
    Girard AE; Schelkly WU; Murphy KT; Sawyer PS
    Am J Vet Res; 1987 Dec; 48(12):1678-83. PubMed ID: 3501686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
    Acar N; Diri MC; Türkyilmaz FR
    Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the in vitro effectiveness of sulbactam/ampicillin and ampicillin].
    Baykal M; Akalin E
    Mikrobiyol Bul; 1987 Jan; 21(1):16-9. PubMed ID: 3441224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
    Greenberg RN; Baker M; Meade DW; Chang Y; Danko LS
    J Antimicrob Chemother; 1993 Dec; 32(6):912-3. PubMed ID: 8144438
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H; Heizmann W; Heilmann F
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
    Xu W; Chen X
    Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activities of aztreonam and sulbactam/ampicillin for gram-negative bacteria].
    Ozkuyumcu C; Durupinar B; Dikmen N
    Mikrobiyol Bul; 1989 Jan; 23(1):77-9. PubMed ID: 2626099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ampicillin/sulbactam on human polymorphonuclear leukocyte function.
    Pascual A; Conejo MC; López Lopez G; Perea EJ
    Chemotherapy; 1991; 37(5):335-42. PubMed ID: 1666546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H
    Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of sulbactam-ampicillin on renal function].
    Kaya IS; Dilmen U
    Mikrobiyol Bul; 1987 Jul; 21(3):178-80. PubMed ID: 3503960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of antibiotics in combination. The antibacterial activity of blood serum and urine after a simultaneous administration of aminoglycosides and ampicillin.
    Janovská D; Výmola F; Godová T
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(1):33-9. PubMed ID: 6425397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association experiments in antimicrobial susceptibility testing of aerobes and anaerobes to ampicillin and ampicillin plus sulbactam.
    Heizmann WR; Werner H; Heilmann F
    J Chemother; 1989 Jul; 1(4 Suppl):315-6. PubMed ID: 16312418
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro effect of ampicillin/sulbactam on Acinetobacter species.
    Hostacká A
    Microbios; 2001; 106 Suppl 2():97-104. PubMed ID: 11548205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ampicillin plus sulbactam in vitro activity against anaerobes.
    Heilmann F; Heizmann W; Werner H
    Drugs; 1988; 35 Suppl 7():84-8. PubMed ID: 3220012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.